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Histone deacetylase inhibitorPublicly available gene expression proﬁles of the hippocampus measured during the successful administra-
tion of the histone deacetylase inhibitor, CI-994, to assist the extinction of mice contextual fear conditioning
were re-analyzed using the recently proposed principal component analysis based unsupervised feature
extraction. We identiﬁed 30 genes associated with differential gene expression in the hippocampus of mice
treated with the HDAC inhibitor compared to controls; most of these genes code for postsynaptic density
proteins. These 30 genes signiﬁcantly overlapped with those detected by treatment with another HDAC
inhibitor, FTY720, during similar contextual fear conditioning. However, because the 30 genes did not strongly
overlap with genes associated with histone acetylation during contextual fear conditioning, altered histone
modiﬁcation in response to HDAC inhibitor treatment might not be the primary mechanism of effective
extinction of contextual fear conditioning. Based on the results of our analyses we propose that HDAC
inhibitors affect the temporal expression of the above genes via direct as well as indirect mechanisms that
involve calcium signaling.
© 2016 The Author. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Post-traumatic stress disorder (PTSD) is a psychologically impor-
tant disorder that affects human behavior, but also causes other
diseases including heart failure (Taguchi et al., 2015a). The extinction
of fear conditioning is critically important for the treatment of PTSD
(VanElzakker et al., 2014). The use of rodent models of fear memory
conditioning is useful to investigate the mechanisms involved in
memory formation (Baldi and Bucherelli, 2015). Fear conditioning as
well as its memory retention can be detected in animals by careful
observation of animal behavior (freezing reaction). The use of omics
data analyses (Hong et al., 2013), e.g., gene expression analyses, has
helped our understanding of the molecular biological background of
memory formation. Primary important brain regions for fear memory
formation include the amygdala and hippocampus (Zelikowsky et al.,
2014). Gene expression and epigenetic markers have been observed
for formation, extinction, and retrieval of fear memory in the short
and long term, in drug treatment and in gene knock out studies
(Mamiya et al., 2009; Lin et al., 2011; Havekes et al., 2008; Yamada et
al., 2009).c. This is an open access article undRecently, the epigenetic effect on fear memory formation has
attracted researchers’ interests. Epigenetic effects are considered to be
related to long term memory (Gupta et al., 2010), because it can be
maintained for longer periods while displaying plasticity. Thus,
epigenetics might have a role in long term memory including fear
memory formation.
The extinction of fear memory by retrieval of the fear memory itself
is an interesting subject, because the extinction of fear memory is not
thought to erase the old memory but rather to form new memory that
overwrites the old fear memory. Generally, the extinction of a short
term fear memory by retrieval is easy but it is more difﬁcult to
extinguish a remote long term memory (Inda et al., 2011). Recently,
Gräff et al. (2014) showed that the successful extinction of a remote
contextual fear memory was aided by treatment with an inhibitor of
histone deacetylation, CI-994 (HDACi). Histone deactylation affects
brain function; speciﬁcally it has been implicated in fear memory
extinction (Volmar and Wahlestedt, 2015; Whittle and Singewald,
2014). Gräff et al. suggested that the altered histone acetylation of key
genes in the hippocampus by CI-994, was essential for the effective
extinction of contextual fear memory.
In this study, we re-analyzed the gene expression proﬁles
measured by Gräff et al. (2014) and found that 30 genes in the
hippocampus were signiﬁcantly and differently expressed betweener the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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signiﬁcantly overlapped with the altered expression of hippocampal
genes induced by treatment with another HDAC inhibitor, FTY720
(Hait et al., 2014). In addition, these genes did not overlap with genes
associated with a previous study (Park et al., 2013) investigating
histone acetylation during contextual fear conditioning in the
hippocampus. This suggests that the extinction of a contextual fear
memory cannot be fully mediated by the alteration of histone
acetylation in the hippocampus. We propose that the altered gene
expression in the hippocampus by HDACi treatment is mediated not
through histone acetylation but rather by inhibition of the direct
regulation of target genes by HDAC, speciﬁcally HDAC4, as well as
regulation through transcription factors including EGR1. This
indicates the difﬁculty and complexity of interpreting altered gene
expression induced by HDACi treatment.
2. Methods
2.1. Hippocampus gene expression
We used mouse gene expression proﬁles from two remote
contextual fear memory extinction experiments (Gräff et al., 2014;
Hait et al., 2014) mediated by two distinct HDAC inhibitors. GSE53794
(Gräff et al., 2014) is a gene expression proﬁle measured by next
generation sequencing (NGS) technology. It is composed of sixﬁleswith
three HDACi CI-994 treated samples and three control samples.
Downloaded SRA format ﬁles were converted to fastq ﬁles by
fastq-dump in SRA Toolkit 2.4.5 (Bethesda, 2011). Then, the obtained
fastq ﬁles were mapped to the mm10 genome via TopHat (Kim et al.,
2013). The obtained sam ﬁles were processed via SAMtools (Li et al.,
2009) and htseq-count (Anders et al., 2015). Finally, we obtained the
gene expression proﬁles of the RefSeq genes. GSE57015 (Hait et al.,
2014) was measured by microarray and was composed of eight ﬁles
with four HDACi FTY720 treated samples and four control samples. The
provided CELﬁleswere standardized viamas5 function implemented in
the AFFY (Gautier et al., 2004) package (Bioconductor Gentleman et al.,
2004) and gene expression proﬁles were extracted. GSE3963 (Keeley et
al., 2006) was also measured by microarray and was composed of 26
samples, containing 8 fear conditioning (FC), 8 conditional stimulation
(CS) and 10 normal (N) samples. Gene expression proﬁles stored in a
series matrix were normalized to have a mean of zero and a variance of
one, and were used because no raw data was provided.
2.2. Hippocampus histone acetylation
Histone acetylation proﬁles were obtained from GSE30325 (Park
et al., 2013) where genome wide H4K5ac was measured after a
contextual fear conditioning mice experiment with Chip-Seq
technology. Two wig ﬁles (GSM751963_CON_H4K5_IC_norm.wig.gz
and GSM751966_FC_H4K5_IC_norm.wig.gz) that corresponded to
control and H4K5ac treated proﬁles were downloaded. wig ﬁles
were processed with the ﬁndOverlaps function in rtracklayer
(Lawrence et al., 2009) packages (Bioconductor) towards the down/
upstream of 1000 bps from transcription start sites of refseq genes
(mm9). Refseq gene ids were converted to gene symbols by the
biomaRt (Durinck et al., 2009) package (Bioconductor).
2.3. Principal component analysis based unsupervised feature extraction
Although our proposed method, PCA based unsupervised FE, was
extensively and successfully applied to various biological problems
(Taguchi, 2014, 2015; Taguchi et al., 2015a, 2015b, 2015c; Umeyama
et al., 2014; Murakami et al., 2012, 2014, 2015; Taguchi and
Murakami, 2013, 2014; Kinoshita et al., 2014; Ishida et al., 2014;
Taguchi and Okamoto, 2012), we brieﬂy review the methodologyhere. Basically, it is composed of two parts, gene embedding parts and
gene selection parts (Fig. 1).
In brief, PCA based unsupervised FE, in contrast to the ordinary
usage of PCA, uses features (genes) embedded into the low
dimensional space rather than samples. After specifying PCs that
exhibit biological signiﬁcance, features as outliers along the speciﬁed
PC are extracted as important features. The philosophy behind this
methodology is that if a set of features have common dependence
upon samples, no matter what they are, they are more likely to
construct PCs because PCs represents the majority of behaviors. PCs
that exhibit clear sample dependence likely represent biological
signiﬁcance, e.g., the distinction between control and treated samples.
Although there is no evidence to support this hypothesis, it is such a
simple methodology that it is not computationally challenging at all,
thus is worthwhile trying. Gene expression proﬁles are normalized so
as to have a mean of zero and unit variance before applying PCA.
2.4. Gene embedding by PCA
Suppose that we have mRNA expression xij of ith mRNA of jth
sample. It is also supposed that 1N∑
i
xij ¼ 0and 1N∑
i
x2ij ¼ 1where N is
the number of genes. X is the matrix whose element is xij. In contrast
to the usual usage of PCA, where samples are embedded, genes
(mRNAs) are embedded in the PCA based upon unsupervised FE. Then
kth principal component (PC) score uki attributed to ith gene can be
computed as the element of eigen vector uk of the grammatrix G≡XXT,
XXTuk=λkuk where λk is eigen value ordered such that λk+1bλk. The
kth PC loading vkj attributed to jth sample can be computed as the
element of vk=XTuk, which is eigen vector of the matrix XTX, since
XTXvk=XTXXTuk=XTλkuk=λkvk.
2.5. Sample embedding PCA
Gene embedding has the tight relationship with the ordinary
sample embedding. In sample embedding, it is also supposed that
1
M∑
j
xij ¼ 0 instead of that 1N∑
i
xij ¼ 0 and 1N∑
i
x2ij ¼ 1 where M is the
number of samples. Then instead of gram matrix G≡XXT, covariance
matrix S≡XTX was diagonalized. Eigen vector uk of the covariance
matrix S is PC scores attributed to each sample, while vk=Xuk is PC
loadings attributed to each genes.
Thus the principal difference between sample embedding and
gene embedding is either 1N∑
i
xij ¼ 0 or 1M∑
j
xij ¼ 0 , but this
difference can generally matter so much, since PCA is the diagona-
lazation of the product of X, not X itself. Thus, the effect of row-wise or
column-wise mean extraction is unpredictable. These two generally
give us distinct outcomes.
2.6. Feature extraction
In PCA based unsupervised FE, gene embedding was performed.
Then after identifying a set Ωk of PCs whose PC loading are coincident
with the distinction between treated and control samples,
outlier genes were identiﬁed by assuming Gaussian distribution of
PC scores using χ squared distribution, Pi ¼ P

N∑
k∈Ωkðukiσk Þ
2

, where
P[Nx] is cumulative probability of χ squared distribution when the
argument is larger than x and σk is standard deviation of kth PC scores.
Then, if BH criterion (Benjamini and Hochberg, 1995) adjusted Pib0.01,
ith gene is identiﬁed as outlier.
P-values were attributed to PC scores associated with each gene by
assuming χ squared distribution (degree of freedom is one for
GSE53794 and two for GSE57015 and GSE3963, based on the number
of PCs used for extraction). P-values were adjusted by Benjamini and
C
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Fig. 1. Schematics of PCA based unsupervised FE. Among N genes, limited number of genes are distinct between two classes composed ofM samples (Top left). After embedding N
genes into low dimensions (top right), outliers (red crosses) are extracted using PC loadings attributed to samples (bottom), which exhibit distinction between two classes (red and
blue ﬁlled circles).
3Y.-H. Taguchi / Neuroepigenetics 8 (2016) 1–18Hochberg (BH) criterion (Benjamini and Hochberg, 1995). Genes
associated with adjusted P-values less than 0.05 (for GSE53794 and
GSE3963) and 0.01 (for GSE57015) were extracted for further
analyses. Distinct threshold P-values were used for these three gene
expression proﬁles because of the different signiﬁcances between the
three data sets. P = 0.01 is too small for GSE53794 and GSE3963 and
results in too few genes extracted whereas P = 0.05 is too large for
GSE57015 and results in too many extracted genes. Obtained P-values
for GSE53794 and GSE57015 (not adjusted) were also used for the
computation of correlation coefﬁcients between the two P values.
To apply PCA based unsupervised FE to gene expression proﬁles
taken from GSE3963 (Keeley et al., 2006), we used categorical
regression that assumed
vkj ¼ Ck0 þ
X
s
C
k
s δjs þ Ckt t j
where vkj is the contribution to the kth PC from the jth sample,
C0
‘ ,Csk,Ctk are the regression coefﬁcients, and values in all categories
were summed. δjs takes 1 only when jth sample belongs to sth
category otherwise 0. tj is the time point of jth sample. P values were
attributed to each k and PCs with P b 0.05 were considered signiﬁcant
(Fig. 2).
2.7. Other analytical methods
2.7.1. t test based FE
Because the t test requires class standard deviation, genes
associated with class constant variables in either class are excluded.
Then, P-values were computed with a two-sided t test and P-values
were adjusted by BH criterion. Genes associated with adjusted
P-values less than 0.05 were signiﬁcant.2.7.2. Categorical regression based FE
Categorical regression is described by the following equation:
xij ¼ Ci0 þ
X
s
C isδjs
where xij is the gene expression of ith gene of jth sample. Ci0 and Ciss
are regression coefﬁcients. δsj is 1 only when jth sample belongs to sth
class, otherwise it is 0. Category (in this case, there are only two
categories, i.e., control and treated) summation was performed. P
values were computed with the F test based on regression results.
P-values were adjusted by BH criterion. Genes associated with
adjusted P-values less than 0.05 were signiﬁcant.
2.7.3. Limma
The Limma (Ritchie et al., 2015) package (Bioconductor) was used
for this test. Although inputs to Limma should be logarithmic
transformed values, because the gene expression in GSE53794 included
too many zero values that cannot be logarithmically transformed, we
employed two alternative methodologies. First, we used raw values
instead of using logarithmic transformed values. Second, gene expres-
sionwas logarithmically transformed after removing geneswith at least
one zero value. Genes towhich adjusted P values less than0.05provided
by Limma were extracted for further analyses.
2.8. Comparison between H4K5ac and gene expression
Alterations in gene expressionwere transformed to P-values assuming
χ2-distribution (see the above subsection “Principal component analysis
based unsupervised feature extraction”). The correlation coefﬁcient
between P-values and differential H4K5ac between control and contex-
tual fear conditioning groups was computed.
Gene expression
HDACi: CI-994,     FTY720 
30 genes
Evaluations
DAVID, g:profiler, TargetMine, 
STRING, GeneMania,  FNTM, 
Enricher, ENCODE
Genes with
Histone 
Acethylation
363 genes
“Long-term potentation” through 
“calcuim signaling pathway”
PSD proteins,
HDAC4 target,
TFs (incl.Egr-1)
Fear extinction
PCA based unsupervised FE
Fig. 3. Over all ﬂow chart of analyses performed in this study.
Hippocampus gene expression
Contextual fear conditioning
(HDACi treatment vs control)
CI-994
(GSE53794)
FTY-720
(GSE57015)
Cued fear conditioning
(FC, CS, N)
(GSE3963)
PCA based unsupervised FE ( χ square dist.)
30 genes362 genes
PC2
(P<0.05)
PC3+PC4
(P<0.01)
PC1+PC2
(P<0.05)
242 genes
11 genes
(P=3.11 ×10-12)
11 genes
(P=5.92 ×10-12)
Fig. 2. Schematic of PCA based unsupervised FE applied to three gene expression proﬁles in mice hippocampus. Analysis was conducted after contextual (GSE53794 and GSE57015)
and cued (GSE3963) fear conditioning. Patients in the two contextual fear conditioning groups were treated with HDACi (CI-994 for GSE53794 and FTY-720 for GSE57015). PCs used
for FEs and P values that represent signiﬁcant overlaps (and attributed P values for the amount of overlap) are also shown.
4 Y.-H. Taguchi / Neuroepigenetics 8 (2016) 1–182.9. PPI identiﬁcation via STRING and Gene-gene interaction
identiﬁcation via GeneMania and FNTM
For all servers, gene symbols used for enrichment analyses were
uploaded. For STRING, after selecting “multiple proteins” menu,
organismwas speciﬁed in the pull downmenubelow (“Musmusculus”).
“PPI enrichment p-value” will appear under “Analysis” tab. For
GeneMania, in “Customise Advanced Options” menu, both “Max
resultant genes/attributes” were set to be zero so as to identify only
interaction within uploaded genes. For FNTM, after specifying targeted
tissue as “hippocampus pyramidal layer”, “Minimum relationship
conﬁdence” and “Maximum number of genes” were chosen to be 0.5
and 0, respectively.
2.10. ENCODE data visualizations
ENCODE data on genome (https://genome.ucsc.edu/ENCODE/)
was drawn as follows. As for gene identiﬁer, refseq was selected. As
for histone acetylation, under the “Regulation” section, in “Integrated
Regulation from ENCODE Tracks”, “Layered H3K4Me1”, “Layered
H3K4Me3” and “Layered H3K27Ac” were selected. Under “ENCODE
Histone Modiﬁcation Tracks” section, in “Broad Histone”, “SYDH
Histone” and “UW Histone”, all histone acetylation trucks and HDAC
trucks were selected. As for EGR1 binding, under “ENCODE Transcrip-
tion Factor Binding Tracks”, in “HAIB TFBS”, “egr-1” was selected.
3. Results
Overall ﬂow chart of the analyses performed in this study is
available in Fig. 3.
3.1. PCA based unsupervised FE identiﬁed genes with altered expression
associated with HDACi treatment
To identify genes differently expressed between the control and
treated (by HDACi) samples, we used PCA based unsupervised FE that
extracts critical genes effectively even when there are only slightdifferences between the two classes. In this regard, PCAwas applied to
gene expression proﬁles taken from GSE53794 and genes were
embedded into two-dimensional space (Fig. 4). Fig. 5 shows the
Fig. 4. Two dimensional embedding of genes, uik , (k=1,2), by applying PCA to gene
expression. Data was from GSE53794 (treated with CI-994). Each circle represents an
individual gene. Circles in red correspond to genes extracted (Table 1).
5Y.-H. Taguchi / Neuroepigenetics 8 (2016) 1–18contributions to each PC from each sample (loadings). Although PC1
had a large contribution (95 %), it did not clearly exhibit sample
dependence. However, although PC2 had a small contribution (3.8 %),
it exhibited a slight but signiﬁcant (P = 0.05 by t test) distinction0.
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Fig. 5. Contributions to each PC from each sample, vkj ,(k=1,… ,4), that corresponds to Fig. 4
PC2 has a signiﬁcant P value (0.05 by t test) that corresponds to signiﬁcant distinction betwbetween control and treated samples while both PC3 and PC4 with
fewer contributions showed no signiﬁcant distinctions between
control and treated samples (by t test). Thus, we selected genes as
outliers along PC2 as shown in Fig. 4 (see methods). The selected
genes are listed in Table 1. The expression of individual genes is
shown in Additional ﬁle 1.
Although using the strict statistical test successfully identiﬁed
genes that had signiﬁcantly different expression between the control
and treated samples, a single experiment is not sufﬁcient to determine
the reliability of selection. The selection needs to be supported by an
independent data set. PCA was again applied to alternative gene
expression proﬁles obtained fromGSE57015 (seemethods) and genes
were embedded into two-dimensional space (Fig. 6). Fig. 7 represents
the contributions to each PC from each sample. In contrast to Fig. 5,
there was no single PC that exhibited signiﬁcant differences between
controls and treated samples. After numerous experiments, we found
that signiﬁcance could only be detected when PC3 is combined with
PC4 as one vector (Fig. 8, P = 0.04 by t test). Therefore, we selected
genes with larger PC3 and PC4 scores (Fig. 6, full list is available in
Additional ﬁle 3). Three hundred sixtyfour genes were identiﬁed as
outliers. However, given that the total number of genes included in
this microarray was approximately 2∼3×104 the number of genes
identiﬁed as outliers (ﬁlled in red) represented a relatively small
percentage (2.2%) of total genes. Next we determined whether genes
selected using gene expression data obtained from GSE53794 (treated
with CI-994) and those using gene expression data obtained from
GSE57015 (treated with FTY720) showed signiﬁcant overlap. Among
the 30 genes selected using gene expression taken from GSE53794, 11
genes were also selected using gene expression data from GSE57015.−
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Table 1
Thirty genes identiﬁed by applying PCA based unsupervised FE to gene expression proﬁles. Data was from GSE53794 (treated with CI-994). A: Identiﬁed when using alternative gene
expression proﬁles from GSE57015 (treated with FTY720). B: *:Included in PSD seed network Bar-shira and Chechik (2013), †(‡): identiﬁed as PSD by g:proﬁler (Table 2)
(TargetMine (Table 3)). C: Identiﬁed as targeted by HDAC4 (Sando et al., 2012). D: Associated with differential H4K5ac Park et al. (2013), added to emphasize no overlaps). E:
Temporal gene expression after cued fear conditioning Keeley et al. (2006).
Gene full names MGI A B C D E
Adcy1 adenylate cyclase 1 99677
Atp1a3 ATPase, Na+/K+ transporting, alpha 3 polypeptide 88107 *
Atp2b1 ATPase, Ca++ transporting, plasma membrane 1 104653
Calm1 calmodulin 1 88251 * * *
Calm3 calmodulin 3 103249 *
CAMK2A calcium/calmodulin-dependent protein kinase II alpha 88256 *,† ,‡ * *
Camk2B calcium/calmodulin-dependent protein kinase II, beta 88257 *,† ,‡ *
Chn1 chimerin 1 1915674 *
Cplx2 complexin 2 104726 *
Cyﬁp2 cytoplasmic FMR1 interacting protein 2 1924134 *
Ddn dendrin 108101
Dnm1 dynamin 1 107384 * * *
Enc1 ectodermal-neural cortex 1 109610 * *
Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 1321390 *
Fth1 ferritin heavy chain 1 95588 * *
Gria1 glutamate receptor, ionotropic, AMPA1 (alpha 1) 95808 * *,† ,‡
Kif5A kinesin family member 5A 109564 *
Lars2 leucyl-tRNA synthetase, mitochondrial 2142973
Meg3 maternally expressed 3 1202886
Ncdn neurochondrin 1347351 * *
Nptx1 neuronal pentraxin 1 107811
Nrgn neurogranin 1927184 † *
Ppp3ca protein phosphatase 3, catalytic subunit, alpha isoform 107164 * * * *
Ppp3r1 protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I) 107172 * *
Ptk2b PTK2 protein tyrosine kinase 2 beta 104908 *,† ,‡
Slc1a2 solute carrier family 1 (glial high afﬁnity glutamate transporter), member 2 101931 *
Syt1 synaptotagmin I 99667 * *
Ttr transthyretin 98865 *
Xist inactive X speciﬁc transcripts 98974
Rn45s 45S pre-ribosomal RNA —
6 Y.-H. Taguchi / Neuroepigenetics 8 (2016) 1–18Considering that the number of genes selected using gene expression
from GSE57015 is a small percentage of the total number of genes
included in GSE57015, this amount of overlap is clearly signiﬁcant.Fig. 6. Two dimensional embedding of genes by applying PCA to gene expression,
uik , (k=3,4). Data was from GSE57015 (treated with FTY720). Each circle represents an
individual gene. Circles in red correspond to genes extracted.Computation of the P value using Fisher's exact test showed P=
5.92×10−12. To strengthen the observed signiﬁcant coincidence, we
also computed the correlation coefﬁcients of P values between
GSE53794 and GSE57015 (see methods and Fig. 9). A correlation
coefﬁcient of 0.40 was associated with a P value of zero within
computational accuracy. This suggested that gene expression differ-
ences induced by two distinct HDAC treatments could be successfully
identiﬁed using these methods. Thus the gene selection shown in
Table 1 is likely.
3.2. Selected genes were reported to be related to brain functions/
dysfunctions
The 30 genes identiﬁed in this study (Table 1) were previously
reported to be related to brain functions, or the development of disease.
For examples, pairs of proteins that form a complex (e.g. calcineurin is
composed of Ppp3ca and Ppp3r1), and non-coding RNAs (Meg3 and
Xist) that are related to brain functions were detected (for more details
and other genes, see Additionalﬁle 9). This suggested the feasibility and
usefulness of ourmethodology aswell as the ability to detect genes that
might be related to fear memory forming factors.
3.3. Enrichment analysis of selected genes
In addition to performing a literature search in the previous section,
we also validated the set of genes byenrichmentanalysis.Weuploaded a
list of 30 genes (Table 1) to three enrichment analysis gateways,
g:Proﬁler (Reimand et al., 2011), TargetMine (Chen et al., 2011) and
DAVID (Huang et al., 2009). Multiple biological terms were enriched by
these gateways, some ofwhichwere related to brain/neuronal functions
(Tables 2, 3 and 4, full list is available in Additional ﬁle 2). Because no
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Fig. 7. Contributions to each PC from each sample, vkj , (k=1,… ,4), that corresponds to Fig. 6. Contributions are 99% (PC1), 0.36 % (PC2), 0.25 % (PC3) and 0.15 % (PC4), respectively.
7Y.-H. Taguchi / Neuroepigenetics 8 (2016) 1–18terms for mouse are detected by DAVID, we listed terms for humans.
Despite the distinct criteria of signiﬁcance between TargetMine and
g:Proﬁler, these two sets of signiﬁcantly enriched biological terms are
well coincident with each other. Although terms detected by DAVID are−
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Fig. 8. Combined PCs with -PC3 and PC4 shown in Fig. 7.relatively small, most were also detected by either of the other two
methods. The number of terms listed in Tables 2, 3 and 4 are large
enough to suggest that the selected genes are globally related to brain/
neuronal functions/diseases.3.4. Gene-gene interaction analysis
As presented above, the individual genes are related to synaptic/
neuronal activities, the selection of genes is likely to be promising. We
also wanted to test whether they act cooperatively. To test this this
assumption, we uploaded the 30 genes to GeneMania (Zuberi et al.,
2013). GeneMania integrates various interactions between genes from
variety of sources. We found that these 30 genes were identiﬁed to be
highly co-expressed, co-localized and genetically related (Fig. 10),
although this is highly context dependent.
We also performed protein–protein interaction enrichment anal-
ysis using text based gene interaction identiﬁcation server, STRING
(Szklarczyk et al., 2015) that also integrates various PPIs, which
detected 29 interactions compared with the expected number of 6
(P=4.9×10−12).
One may still wonder if this analysis is tissue speciﬁc. In order to
further conﬁrm these ﬁndings in a tissue speciﬁc manner, we uploaded
30 genes to Functional Networks of Tissues in Mouse (FNTM), a mouse
tissue speciﬁc interaction identiﬁcation/enrichment analysis server
(Goya et al., 2015) (Fig. 11 and Table 5). Then, we found that 21 out of
27 genes identiﬁed by FNTM are inter-related in the mouse in a tissue
speciﬁc manner. The top most two enrichment KEGG pathways
identiﬁed were “Long-term potentiation” (mmu04720) and “Calcium
signaling pathway”(mmu04020). This suggested that 27 genes contrib-
uted to long-term potentiation through calcium signaling pathway.
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Table 2
Enrichment analyses of the 30 selected genes via g:Proﬁler (Reimand et al., 2011).
Asterisked terms are also listed in Table 3.
g:Proﬁler
GO BP
Modulation of synaptic transmission 1.76E-09 GO:0050804 *
Synaptic signaling 1.96E-07 GO:0099536 *
Trans-synaptic signaling 1.96E-07 GO:0099537 *
Synaptic transmission 1.96E-07 GO:0007268 *
Regulation of synaptic plasticity 7.78E-07 GO:0048167 *
Positive regulation of synaptic transmission 2.52E-05 GO:0050806
Nervous system development 1.04E-05 GO:0007399
Neurogenesis 5.65E-05 GO:0022008 *
Regulation of synapse structure or activity 2.67E-05 GO:0050803 *
Generation of neurons 3.37E-04 GO:0048699
Neuron differentiation 1.36E-03 GO:0030182
Neuron development 1.71E-04 GO:0048666 *
Neuron projection development 3.78E-05 GO:0031175 *
Neuron projection morphogenesis 3.62E-02 GO:0048812 *
Cell morphogenesis involved in neuron
differentiation
4.43E-02 GO:0048667
GO CC
Neuron part 3.75E-13 GO:0097458 *
Neuron projection 2.02E-13 GO:0043005 *
Neuron spine 3.58E-02 GO:0044309
Axon 1.64E-07 GO:0030424
Axon part 2.07E-02 GO:0033267
Dendrite 9.97E-09 GO:0030425 *
Dendritic spine 3.52E-07 GO:0043197
Neuron projection membrane 4.69E-02 GO:0032589 *
Neuronal cell body 1.01E-06 GO:0043025 *
Synapse 4.67E-08 GO:0045202 *
Synapse part 4.60E-08 GO:0044456 *
Postsynaptic density 6.38E-03 GO:0014069 *
Excitatory synapse 3.53E-04 GO:0060076
Postsynapse 5.62E-04 GO:0098794 *
Postsynaptic specialization 6.38E-03 GO:0099572 *
KEGG
Glioma 2.95E-02 KEGG:05214 *
Dopaminergic synapse 2.90E-05 KEGG:04728 *
Long-term potentiation 7.71E-09 KEGG:04720 *
Amyotrophic lateral sclerosis (ALS) 3.80E-04 KEGG:05014 *
Glutamatergic synapse 3.57E-04 KEGG:04724 *
Synaptic vesicle cycle 2.34E-02 KEGG:04721 *
REACTOME
Neuronal System 1.81E-04 REAC:7083291 *
Neurotransmitter receptor binding and
downstream transmission in the postsynaptic cell
1.52E-03 REAC:7083523 *
Activation of NMDA receptor upon glutamate
binding and postsynaptic events
2.59E-06 REAC:7083522 *
8 Y.-H. Taguchi / Neuroepigenetics 8 (2016) 1–18Thus, genes in Table 1 includedmany intra-related proteins, possibly
including protein complexes, functioning together that may have
co-evolved, althoughwhat kind of co-operation took place is unclear yet.
3.5. Comparison with other methods
To test the validity of ourmethodology, we tested other alternative
methods to identify genes associated with a signiﬁcant different
expression between treated and control samples. We considered gene
expression from GSE53794, because it has a smaller number of
signiﬁcant genes. If other methods cannot identify signiﬁcant genes or
the identiﬁed signiﬁcant genes are not biologically plausible then
further analysis should not be performed.
First, we investigated t test based FE. However, this method
identiﬁed no signiﬁcant genes. Second, we investigated categorical
regression based FE and identiﬁed 23 signiﬁcant genes (see methods
andAdditionalﬁle 3). Although thenumber of identiﬁed geneswas only
slightly smaller than the number of signiﬁcant genes identiﬁed by PCA
based unsupervised FE, TargetMine, g:Proﬁler or DAVID methods did
not identify signiﬁcant biological terms associatedwith the genes. Thus,
we did not perform any further analyses of these genes. Limmawas also
used to analyze gene expression from GSE53794 (see methods). Using
logarithmic transformed values, we did not identify any signiﬁcant
genes.When rawvalueswere used, 24 signiﬁcant geneswere identiﬁed
(see Additional ﬁle 3); however, TargetMine, g:Proﬁler, and DAVID did
not identify any signiﬁcant biological terms associatedwith these genes.
Thus, no further analysis was performed for these genes.We found that
genes selected by categorical regression and those by Limma showed
some overlap with 23 genes are common. This indicates a limitation of
supervised FEs including the t test, categorical regression and Limma.
Finally, we compared our results with those obtained by Gräff et al.
(2014). Although Gräff et al. (2014) reported the successful
identiﬁcation of 475 differentially expressed genes between control
and treated samples, there are a number of limitations including: (i)
Pb0.05 was used as a signiﬁcance criterion without adjusting the P
values and (ii) they did not provide explanations why the threshold
fold change was determined to be 1.4; thus, there was no statisticaljustiﬁcation. When 475 genes were uploaded to annotation gateways,
the number of obtained signiﬁcant biological terms (Table 6) did not
outperform those in Tables 2, 3 and 4 although the number of genes
uploaded are ﬁfteen times more. Although BP and MF GO terms are
more in genes identiﬁed by Gräff et al while CC GO terms are at most
comparative and pathway enrichments were less in genes identiﬁed
by Gräff et al.(often zero). Maximum ratio of genes that individual TF
target is 84.6 % for 30 genes in Table 1 while 4.5 % for genes identiﬁed
by Gräff et al. Of note, using these other methods, no signiﬁcant
biological terms would be obtained if 30 genes (the number of genes
in the current study) were uploaded. This might explain why Gräff et
al did not adjust the P values or did not use the fold change threshold
larger than 1.4, thereby resulting in a small number of genes that gave
no signiﬁcant biological terms. Thus, we believe the genes identiﬁed
in the current study are more reliable than those reported by Gräff et
al. (2014). (see Tables S1, S2 and S3 for summary of biological term
enrichments related to neuron/synapse; the full list is available as
Additional ﬁle 4).
Although other more complicated or computationally challenging
methods might be useful for identifying signiﬁcant genes associated
Table 3
Enrichment analyses of the 30 selected genes via TargetMine (Chen et al., 2011).
Asterisked terms are also listed in Table 2.
TargetMine
GO BP
Modulation of synaptic transmission 1.04E-03 GO:0050804 *
Synaptic transmission 1.04E-03 GO:0007268 *
Regulation of synaptic plasticity 4.90E-03 GO:0048167 *
Synaptic signaling 1.04E-03 GO:0099536 *
Trans-synaptic signaling 1.04E-03 GO:0099537 *
Neuron projection development 5.84E-03 GO:0031175 *
Neuron development 1.97E-02 GO:0048666 *
Neuron projection morphogenesis 2.87E-02 GO:0048812 *
Regulation of synapse structure or activity 3.15E-02 GO:0050803 *
Neurogenesis 4.26E-02 GO:0022008 *
GO CC
Neuron part 4.12E-06 GO:0097458 *
Synapse 2.30E-05 GO:0045202 *
Neuron projection 1.02E-04 GO:0043005 *
Dendrite 3.62E-03 GO:0030425 *
Postsynaptic density 4.50E-03 GO:0014069 *
Synapse part 1.16E-02 GO:0044456 *
Somatodendritic compartment 2.75E-03 GO:0036477
Neuron projection membrane 2.26E-02 GO:0032589 *
Neuronal cell body 2.82E-03 GO:0043025 *
Synapse part 2.75E-03 GO:0044456
Postsynapse 2.75E-03 GO:0098794 *
Postsynaptic specialization 4.50E-03 GO:0099572 *
Pathway enrichment analysis
Long-term potentiation 1.30E-09 mmu04720 *
Dopaminergic synapse 1.56E-06 mmu04728 *
Glutamatergic synapse 2.22E-04 mmu04724 *
Amyotrophic lateral sclerosis (ALS) 2.27E-04 mmu05014 *
Glioma 4.76E-04 mmu05214 *
Neurotrophin signaling pathway 3.20E-03 mmu04722
Synaptic vesicle cycle 5.71E-03 mmu04721 *
Alzheimer’s disease 9.22E-03 mmu05010
Activation of NMDA receptor upon glutamate
binding and postsynaptic events
5.51E-08 R-MMU-442755 *
Neuronal System 4.81E-06 R-MMU-112316 *
Neurotransmitter receptor binding and
downstream transmission in the
postsynaptic cell
2.26E-05 R-MMU-112314 *
Glutamate neurotransmitter release cycle 1.30E-02 R-MMU-210500
Axon guidance 1.30E-02 R-MMU-422475
Table 4
Enrichment analyses of the 30 selected genes via DAVID (Huang et al., 2009)
Asterisked terms are also listed in Tables 2 or 3. P values were adjusted by BH criterion
DAVID
GO BP
Synaptic transmission 4.44E-02 GO:0007268 *
Transmission of nerve impulse 2.39E-02 GO:0019226
KEGG
Long term potentiation 8.12E-07 hsa04720 *
Amyotrophic lateral sclerosis (ALS) 3.47E-03 hsa05014 *
REACTOME
Synaptic transmission 1.04E-03 REACT_13685
9Y.-H. Taguchi / Neuroepigenetics 8 (2016) 1–18with signiﬁcant biological terms, PCA based unsupervised FE has
outperformed various conventional and/or advancedmethods inwide
range of topics and has a number of advantages including stability and
being computationally less challenging (Ishida et al., 2014; Taguchi
and Murakami, 2014; Taguchi et al., 2015a).
3.6. Histone acetylation may not be a primary mechanism underlying
altered gene expression in response to HDACi treatment for fear memory
formation/maintenance
Because the selected geneswere speciﬁcally related to brain function/
disease, they might also be related to fear memory formation/
maintenance. Next, we investigated the pathways involved in aberrant
gene expression associated with fear memory formation.
One potential scenario is by inhibiting the deacetylation of histones,
because the samples used in this study were from patients treated with
HDACi. Therefore,we investigatedwhether aberrant histone acetylation
was associated with the genes selected by PCA based unsupervised FE
when fearmemories are formed. Park et al. (2013) identiﬁed 115 genes
in mouse hippocampus associated with altered histone acetylation
using H4K5ac between pre- and post-contextual fear conditioning.
Surprisingly, there are no overlaps between these 115 genes and the 30
genes identiﬁed in the current study (Table 1), although they conﬁrmed
that H4K12ac is also coincident with H4K5ac and GO terms for.
.enrichment analyses. This is in contrast to the signiﬁcant and large
overlap between genes associated with two HDACi treatments during
contextual fear conditioning (Table 1).
To conﬁrm the reduced coincidence between genes associated with
altered gene expression during contextual fear conditioningwith histone
acetylation by HDACi treatment, we also performed statistical analyses.
Correlation coefﬁcients between gene expression in GSE53794 or
GSE57015 and H4K5ac were 0.04 (P=4×10−4) or 0.02 (P=0.02),
respectively (scatter plots in Fig. 12). Although the correlation was
signiﬁcant, the absolute value of correlation coefﬁcients was too small to
suggest thathistoneacetylation is theprimary factor causing alteredgene
expression during fear memory formation.
Finally, in order to further conﬁrm the lack of signiﬁcant histone
acetylation enrichment in 30 selected genes, we uploaded 30 genes to
Enricher (Chen et al., 2013). Table 8 show the results for ENCODEHistone
modiﬁcation 2015 data set (adjusted P-values b0.1). Although there are
various histone modiﬁcations signiﬁcantly enriched, no histone acetyla-
tion was detected. This is also consistent with our observation of lack of
histone acetylation.
Moreover, if we draw histone modiﬁcation/HDAC binding to
genome around the 30 genes (See Additional ﬁle 8A), the majority of
genes are not associated with either histone acetylation or HDAC
binding, excluding a few exceptions (e.g., Calm1, Calm3, Enc1, Fth1,
Ncdn, Ppp3ca, and Ppp3r1); other genes are only associated with
modest histone acetylation. This is consistent with the assumption that
the gene expression changes of the identiﬁed 30 genes are not mainly
mediated through histone modiﬁcation, since HDACi cannot affect the
expression of genes not associated with massive histone modiﬁcation.
More interestingly, ﬁve genes (Igf2, Adcy6, cFos, Npas4 and
Arc) that Gräff et al. (2014) studied were not always associated with
massive histone acetylation, either (Additional ﬁle 8B). The only gene
associated with massive histone acetylation is cFos. This suggests that
even the gene expression changes identiﬁed by Gräff et al. (2014)
might not be mediated through histone acetylation.
Thus, we expect to ﬁnd other factors that can induce altered gene
expression during fear memory formation.
3.7. Multiple PSD genes detected by PCA based unsupervised FE
While investigating an alternative interpretation of the altered
gene expression induced by HDACi treatment, we noticed that the
genes detected in this study mostly overlapped with proteins
included in the PSD protein network proposed by Bar-shira and
Chechik (2013) (PSD was also an enriched GO term, Tables 2 and 3).
Starting from the network that consists of experimentally validated
protein pairs (seed network), a computationally inferred extended
network including unknown protein pairs was obtained.
Nine of the genes (Calm1, Camk2a, Camk2b, Gria1, Ppp3ca,
Ptk2b, Syt1, Dnm1, and Kif5a) selected in our study (Table 1) were
included in the seed network of the study by Bar-shira and Chechik,
that were built from high conﬁdence interactions (not based on
(A) (B)
(C) (D)
(E) (F)
Fig. 10. Gene-gene interaction identiﬁed by GeneMania. (A) Mouse co-expression, (B) Human co-expression, (C) Mouse co-localization, (D) Human co-localization, (E) Mouse
predicted (i.e., inference based on orthologues), (F) Humen genetic (i.e., co-mutation during radio activity), respectively.
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Fig. 11. Gene-gene interaction identiﬁed by FNTM with specifying “hippocampus pyramidal layer” as targeted tissue.
11Y.-H. Taguchi / Neuroepigenetics 8 (2016) 1–18computational inference). In addition, the seed network included
Atp1a1 and Atp2b2, which are isoforms of Atp1a3 and Atp2b1,
respectively.
More speciﬁcally, Ppp3ca encodes the PP2BA protein that is a
major part of the PSD complex (Gold, 2012). Camk2a and Camk2b
encode CaM kinase II, which binds to CaM protein, encoded by Calm1
and Calm3 to form the PSD complex that binds to PP2BA (Gold, 2012).
Thus, in addition to Calm1, Calm3 can also be regarded as part of PSD.
Therefore, 12 of the 30 genes identiﬁed are included in PSD networks.
Although the functional signiﬁcance of these genes is not fully
understood, these ﬁndings indicate the feasibility of our study.Table 5
Top most ﬁve enriched KEGG pathway identiﬁed by FNTM. Full list is available as
supplementary ﬁles 7. P-vales were FDR corrected. Frequencies (Freq.) were Network
vs Genome.
KEGG Pathways Freq. P-Value Genes
mmu04720 34.8% (8/23) 4.73e-10
Long-term potentiation 0.7% (67/10087)
Calm1 Calm3 Camk2a Camk2b Gria1 Ppp3ca Ppp3r1 Adcy1
mmu04020 39.1% (9/23) 2.02e-8
Calcium signaling pathway 1.8% (181/10087)
Calm1 Calm3 Camk2a Camk2b Ppp3ca Ppp3r1 Ptk2b Atp2b1 Adcy1
mmu05031 30.4% (7/23) 3.02e-8
Amphetamine addiction 0.7% (68/10087)
Calm1 Calm3 Camk2a Camk2b Gria1 Ppp3ca Ppp3r1
mmu04114 30.4% (7/23) 6.40e-7
Oocyte meiosis 1.1% (115/10087)
Calm1 Calm3 Camk2a Camk2b Ppp3ca Ppp3r1 Adcy1
mmu04024 34.8% (8/23) 8.85e-7
cAMP signaling pathway 2.0% (199/10087)
Calm1 Calm3 Camk2a Camk2b Gria1 Atp2b1 Atp1a3 Adcy1The majority of the remaining proteins were also reported to be
related to PSD. Adcy1, a cyclase stimulated by calcium and calmodulin
(e.g., Calm1 and Calm3), is expressed in PSD (Conti et al., 2007). Chn1
binds to MAPK8IP2 (Vinayagam et al., 2011), to which the GO term
(Cellular Component) “neuronal postsynaptic density” (GO:0097481) is
assigned. Cyﬁp2was identiﬁed as a PSD protein differentially expressed
between schizophrenia patients and healthy controls (Focking et al.,
2015). Ddn was originally reported to be a brain-speciﬁc postsynaptic
protein (Kawata et al., 2006). Enc1 was detected in PSD (Chen et al.,
2002). Ncdn interacts with SEMA4C (Ohoka et al., 2001) that interacts
with PSD-95 (Inagaki et al., 1995), the primary protein in PSD. Nrgn is
expressed inPSD (Watsonet al., 1994). Enpp2binds toDlg4 (Arbuckle et
al., 2010), an important hub protein in the PSD network (Bar-shira and
Chechik, 2013). Ttr binds to Ngfr (Vinayagam et al., 2011) to which the
GO term (Cellular Component) “neuronal postsynaptic density”
(GO:0097481) is assigned. Finally, although Cplx2 is not part of PSD, itTable 6
Comparisons of enrichment analysis between 30 genes in Table 1 and those identiﬁed
by Gräff et al. Numbers are those of signiﬁcant GO terms/pathways. % shown in TF is the
maximum ratio of genes targeted by individual TF. BP: biological process, CC: cellular
components, MF: molecular function are GO terms. KEGG is KEGG pathway, REACTOME
is REACTOME pathway, TF is transcription factor.
this study Gräff et al
# of genes 30 475
g:proﬁler TargetMine DAVID g:proﬁler TargetMine DAVID
BP 45 18 31 355 274 105
CC 25 24 19 40 23 28
MF 5 0 13 19 13 43
KEGG 24 36 8 2 0 0
REACTOME 21 134 2 1 0 0
TF 84.6 % — — 4.5 % — —
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Fig. 12. Scatter plots of P-values associated with altered gene expression. Samples were
from patients treated with HDACi and the absolute value of H4K5ac during contextual
fear conditioning. Darker colors indicate a greater number of points. Contour (blue
lines) indicates the number of points included in each square by common logarithmic
(10 is used as base number) scale. (a) CI-994 (correlation coefﬁcient is 0.04) (Gräff et
al., 2014), (b) FTY720 (correlation coefﬁcient is 0.02) (Hait et al., 2014).
12 Y.-H. Taguchi / Neuroepigenetics 8 (2016) 1–18is a presynaptic protein (Salimi et al., 2008) that might cooperate with
postsynaptic proteins.
Thus, in summary, most of the detected genes in our study are
related to PSD and might explain why STRING as well as GeneMania
and FNTM detected enriched protein-protein interactions between
the genes in Table 1. Therefore, the genes with altered expression
induced by HDACi treatment appear to be related to PSD proteins.
3.8. Postsynaptic density and brain function/fear memory
Often structural changes at postsynaptic sites on dendritic spines
are required for the formation and maintenance of long termmemory(Lamprecht and LeDoux, 2004). Because the present study investi-
gated remote fear memory, it is likely that PSD would have a function
in this process.
Many studies have reported the functional importance of PSD in
brain functions. Zhou et al. (2013) reported the altered expression of
PSD proteins in Alzheimer’s Disease (AD). PSD proteins were reported
to be dysfunctional in schizophrenia and other behavioral disorders
(de Bartolomeis et al., 2014). The PSD protein complex functions
include positioning signaling molecules for the induction of long term
potentiation (LTP) and long term depression (LTD) of synaptic
strength (Gold, 2012), which are related to long term (remote) fear
memory formation and maintenance.
PSD proteins have been reported to be related to fear memory
formation (Nagura et al., 2012); fear conditioned mice with PSD
protein dysfunction exhibited a more pronounced freezing reaction.
In addition, PSD-95, a core component of PSD, was reported to be
essential for maintaining fear memory (Fitzgerald et al.). Additional
studies suggest relationships between PSD and fear memory. Lee et al.
(2008) reported that PSD proteins were degraded in the hippocampus
after the retrieval of contextual fear memory. Huang et al. (2014)
investigated mice lacking Cpeb3, a sequence-speciﬁc RNA-binding
protein that conﬁnes the strength of glutamatergic synapses by
translationally downregulating the expression of multiple
plasticity-related proteins, including N-methyl-D-aspartate (NMDA)
receptor and PSD-95. Cpeb3 KO mice exhibit hippocampus-dependent
abnormalities related to both long term spatial memory and the short
term acquisition and extinction of contextual fear memory. Further-
more, cultured Cpeb3 KOneurons also exhibited delayedmorphological
and biochemical responses under NMDA-induced chemical long term
depression (c-LTD). The c-LTD defects in the KO neurons included
elevated activation of Camk2a. More speciﬁcally, Nagura et al. (2012)
reported that PSD malfunction resulted in impaired remote memory in
fear conditioning tests and Kimura et al. (2008) showed that Camk2b
mutations prevented the extinction of remote fear memory. These
ﬁndings are directly related to the present study target, the extinction of
remote fearmemory. AlthoughunderstandingPSD function in long time
memory is an ongoing study, it appears that PSD has an important
relationship with fear memory.
3.9. Alternative mechanism that may underlie gene expression changes
in response to treatment with HDAC inhibitors
3.9.1. HDAC4 targets PSD proteins
Data from our analyses reported here suggest that histone
acetylation might not be the primary mechanism driving gene
expression changes during HDACi treatment. We identiﬁed that a
subset of genes with altered expression code for proteins that belong
to PSD, suggesting that PSD might have a critical role in fear memory
formation. The next question is what regulates the altered PSD protein
gene expression in response to HDACi. Here, we propose that HDAC4,
a type II HDAC, is a regulatory factor of PSD protein gene expression.
HDAC4was reported to govern a transcriptional program essential
for synaptic plasticity and memory (Sando et al., 2012), not through
histone acetylation but by direct binding to DNA. The loss of HDAC4
impairs contextual fear learning only for long periods (Kim et al.,
2012), which is coincident with the scenario presented here. HDAC4
has a functional role in remote fear memory extinction. HDAC4 is an
NMDA receptor-dependent (not via histone deacetylation) transcrip-
tional repressor that regulates a group of “synaptic” genes (Sando et
al., 2012). Among the genes detected in this study (Table 1), seven
genes (Enc1, Atp1a3, Camk2a, Chn1, Ppp3ca, Slc1a2, and Cyﬁp2) were
reported to be directly repressed by HDAC4 (Table S2 (Sando et al.,
2012)). The overlap between genes selected in the current study
(Table 1) and genes directly targeted by HDAC4 is in contrast to the
lack of overlapping genes between those selected in this study and
genes associated with altered H4K5ac during fear memory formation.
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Fig. 13. Two dimensional embedding of genes by applying PCA to gene expression
uik ,(k=1,2). Data was from GSE3963 (cued fear conditioning). Each circle represents
an individual gene. Circles in red correspond to genes extracted.
13Y.-H. Taguchi / Neuroepigenetics 8 (2016) 1–18HDAC4 is strongly localized in PSD (Darcy et al., 2010) in the
cytoplasm, suggesting the functionality of HDAC4 in PSD is related not
to histone acetylation but rather to the direct regulation of the target
gene expression. HDAC4 is reported to bind to PSD proteins; eleven
genes (Ppp2ca, Gnb1, Mapk3, Mapk1, Ywhaz, Ywhae, Ywhah, Ywhab,
Ywhag, Ppp2r1a and Ywhaq) in the PSD seed network (Bar-shira and
Chechik, 2013) bind to HDAC4 as assessed by the Biogrid data base
(Chatr-Aryamontri et al., 2015). Among these eleven genes, six
encode 14-3-3 proteins (those having names starting ywha), which
generally interact with potassium channel proteins (TASK-1, TASK-3
and TASK-5) in PSD (Rajan et al., 2002). These proteins are essential
for the intracellular trafﬁcking of TASK-1 and TASK-3 (Zuzarte et al.,
2009), the importance of which we are just beginning understand
(Kilisch et al., 2015). All of these ﬁndings suggest that the direct
regulation of genes selected in this study by HDAC4 is a reasonable
hypothesis compared with their regulation through the inhibition of
histone acetylation.
In addition, although the HDACi used in the Graff et al. study,
CI-994, was identiﬁed as an inhibitor of HDAC type I, it is also an
inhibitor of HDAC4, a type II HDAC (Moradei et al., 2007). Thus, it is
reasonable to suggest that the effects observed in Graff et al. were
caused via the direct inhibition of HDAC4 by CI-994.
A number of studies have reported a direct relationship between
HDACs and PSD proteins. HDACs regulated CaMKII expression (Backs
et al., 2008) while calmodulin protein encoded by Calm1 and Calm2
binds to Camk2a and Camk2b (Berggard et al., 2006). Calm1 and
Calm2 also bind to Ppp3ca (Berggard et al., 2006). Kosiorek et al.
(2014) reported that Atp2b1 expression was directly affected by
HDACs combinedwith nuclear factors of activated T-cells. Huang et al.
(2012) reported that Atp1a3 was upregulated by the combined
treatment of histone demethylation and histone deacetylation.
Although they conﬁrmed that the treatment altered histone modiﬁ-
cations, an association between histonemodiﬁcation and altered gene
expression of individual genes was not conﬁrmed. They demonstrated
the regulation of Nr2b gene expression in the hippocampus was
through histone acetylation via HDACi (vorinostat), however, the
possibility that the acetylation of non-histone proteins is involved in
memory enhancement by HDACi was not excluded (Fujita et al.,
2012). Thus, there remains the possibility that gene expression was
not mediated via histone modiﬁcation but was instead induced by the
direct interaction between the genes and HDACi (Singh et al., 2010).
Therefore, although Sando et al. (2012) demonstrated that HDAC4
cannot be targeted with inhibitors that bind to catalytic sites of
histone deacetylases because neuronal HDAC4 function requires the
deacetylation of substrates, our analyses suggest that this may be
possible.
3.9.2. Regulation through transcription factors
As suggested above, the direct interaction between HDAC4 and its
target genes is a potential candidate mechanism underlying the gene
expression changes caused by HDACi. However, an alternate mech-
anism could be indirect regulation via transcription factors (TFs). The
ﬁrst candidate TF is EGR1. First of all, EGR1 expressionwas reported to
be regulated by HDAC4 (Chabane et al., 2009; Su et al., 2010). Second,
most of the 30 genes were reported by g:Proﬁler to be targets of EGR1
(see Additional ﬁle 2); EGR1 binding proﬁle around the transcription
start site (TSS) of the 30 genes provided by ENCODE (Additional ﬁle
8C) showed extensive associationwith EGR1 binding to DNA, too. This
suggested that HDACi can alter target genes expression by blocking
the interaction between HDAC4 and EGR1. There are a number of
reports implicating EGR1 in fear memory. Generally, EGR1 is believed
to be related to reconsolidation of fear memory (Baldi and Bucherelli,
2015; Lee et al., 2004), however there are recent reports that link
EGR1 to fear memory extinction as well (Lee et al., 2015; Tedesco et
al., 2014). EGR1 has also been reported to regulate the expression of
PSD-95 (Qin et al., 2015), the core protein of PSD.In addition to this, HIC1 (hypermethylated in cancer 1 protein)
which also targets most of the 30 genes was reported to be regulated
by HDAC4 (Dehennaut et al., 2013), although there are no reports
linking HIC1 to fear memory formation. E2F3 was also reported to be
regulated by HDAC4 through the regulation of miR-200b (Chen et al.,
2014) and targets most of the 30 genes, although there is no evidence
to date that this was related to fear memory.
All of these above suggested that the HDACi inhibition of the
interaction between HDAC4 and three TFs (EGR1, HIC1 and E2F3) can
be yet another plausible candidate mechanism mediating gene
expression changes induced by HDACi.
3.10. Temporal gene expression may be targeted by HDACi
The current study suggests two alternative scenarios to that
proposed by Gräff et al. (2014): the direct regulation of gene
expression by HDACi or regulation through the interaction with TFs
including EGR1, HIC1 and E2F3. Epigenetic markers have functions in
long term memory formation because they maintain plasticity and
genomic states including chromatin modiﬁcation. An important
question is what is the target of HDACi if not histone acetylation?
We suggest that it targets temporal gene expression during fear
memory formation. Generally, gene expression in the hippocampus is
not altered by cued fear conditioning (Keeley et al., 2006) but rather
by contextual fear conditioning. However, even in cued fear
conditioning, trace fear conditioning can alter gene expression in
the hippocampus (Sirri et al., 2010). Applying PCA based unsuper-
vised FE to gene expression data from GSE3963 provided by Keeley et
al. (2006) where the altered expression of genes in the hippocampus
was mediated by fear conditioning, we identiﬁed 242 genes
(Additional ﬁle 3) associated with temporal gene expression without
distinction between CS and FC by employing PC1 and PC2 for FE (see
below and methods). PCA was applied to an alternative gene
expression proﬁle obtained from GSE3963 and genes were embedded
into a two-dimensional space (Fig. 13). Fig. 14 shows the contribu-
tions of the second PC from each sample, while detailed values related
to Fig. 14 are shown in Table 7. Although the PC1 contribution (99.1 %)
was much larger than that of PC2 (0.2 %) (Table 7), the magnitude of
the correlation of coefﬁcients attributed to hours (Ctk) was reversed.,
Table 8
Histone modiﬁcation detected by Enricher with specifying “ENCODE Histone
20 40 60 800.
19
45
0.
19
55
0.
19
65
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1
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−
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1
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2
Fig. 14. PC1 and PC2 (loading) obtained from GSE3963 (cued fear conditioning), vkj , (k=1,2). Black circles, red triangles and green crosses correspond to 8 CS, 8 FC and 10 N samples,
respectively. Solid lines represent corresponding regression results. Contributions of PCs are 99.1 % for PC1 and 0.3 % for PC2, respectively. Numerical details are shown in Table 7.
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Furthermore, as expected, there were no signiﬁcant distinctions
observed between FC (red lines) and CS (black lines), whereas time
dependencies were clearly signiﬁcant. Thus, the results in Table 7 and
Fig. 14 suggest that altered gene expression in the hippocampus
during fear memory formation is strongly related to the temporal
regulation of the target genes. Among the 30 genes in Table 1, eleven
genes (Calm1, Calm3, Camk2a, Camk2b, Dnm1, Fth1, Ncdn, Nrgn,
Ppp3ca, Ppp3r1 and Syt1) were included in the 242 genes associated
with temporal gene expressionwithout distinction between CS and FC
(the P value attributed to this amount of overlap computed by Fisher's
exact test is 3.11×10−12, thus highly signiﬁcant). To determine
whether the gene expression of the selected genes was signiﬁcant we
computed the correlation coefﬁcient between the expression of the 11
selected genes and PC1/PC2 (Additional ﬁle 5). Seven of the 11 gene
expression proﬁles were signiﬁcantly correlated with PC1 and/or PC2.
Thus, HDACi signiﬁcantly targeted genes that had temporal expres-
sion induced by cued fear conditioning. Sirri et al. (2010) suggested
that temporal gene expression in the hippocampus induced by cued
fear conditioning might occur during the formation of fear memory.
Thus, affecting temporal gene expression in the hippocampus during
fear conditioning might indicate that HDACi affected fear memory
extinction by direct regulation of the target genes.modiﬁcation 2015” data set. Only those associated with adjusted P-values b0.1 were
presented.
Term Overlap P.value Adjusted.P.value
1 H3K27me3_bronchial epithelial
cell_hg19
9/2082 1.80e-04 3.27e-02
2 H4K20me1_ﬁbroblast of lung_hg19 9/2000 1.32e-04 3.27e-02
3 H3K27me3_cardiac mesoderm_hg19 11/3485 4.54e-04 5.51e-02
4 H3K4me1_keratinocyte_hg19 8/2000 7.52e-04 6.48e-023.11. Calcium signaling pathway dysfunction may mediate fear
extinction in response to HDACi
Although the set of 30 genes selected by PCA based unsupervised
FE were extensively related to brain function/fear memory and
their expression may have been mediated by alternative mecha-Table 7
Results of categorical regression. Bold numbers indicate signiﬁcance. Errors are 95 %
conﬁdence intervals. P values attributed to regression analysis and attributed to each
coefﬁcient are shown.
C0
‘ Ck
‘ Ct
‘
CS FC N
PC1: P=7.62×10−3
1.97×10−1 0 1.50×10−5 3.11×10−4 −1.15×10−5
±2.33×10−4 0 ±2.11×10−4 ±2.05×10−4 ±2.97×10−6
Pb2×10−16 — P=0.94 P=0.14 P=8.2×10−4
PC2: P=1.57×10−6
−3.28×10−1 0 −1.87×10−2 −1.50×10−1 5.98×10−3
±6.07×10−2 0 ±5.55×10−2 ±5.36×10−2 ±7.75×10−4
P=1.95×10−5 — P=0.94 P=1.04×10−2 P=1.05×10−7nisms than histone modiﬁcation in the promoter regions of target
genes by HDACi, it is intriguing to hypothesize what the exact
alternative mechanisms by which 30 genes contribute to fear
extinction may be.
As can be seen in the above, FNTM identiﬁed calcium signaling
pathway as well as long term potentiation as two top most signiﬁcant
KEGG pathways. Since FNTM is a mouse tissue speciﬁc enrichment
server, its results are most relevant. Moreover, it is especially
remarkable that the calcium signaling pathway is one of the most
important functional parts in PSD (Higley and Sabatini, 2012; Keller et
al., 2008). Thus, in the following we investigate if fear extinction can
be mediated by regulation of the calcium signaling pathway.
Fig. 15 shows the pathway mapping of some of the 30 genes
towards two pathways. In Fig. 15(A), calcium signaling pathway, most
of related genes were placed downstream of Ca2+. These genes were
also placed downstream of Ca2+ in Fig. 15(B), showing long term
potentation. However, Adcy1 was also placed upstream of Ca2+ in the
calcium signaling pathway. This suggests Adcy1 may cause the5 H3K27me3_mammary epithelial
cell_hg19
9/2586 8.90e-04 6.48e-02
6 H3K27me3_kidney_mm9 7/1675 1.34e-03 6.76e-02
7 H3K27me3_kidney epithelial
cell_hg19
8/2217 1.47e-03 6.76e-02
8 H3K27me3_keratinocyte_hg19 8/2221 1.49e-03 6.76e-02
9 H3K4me1_embryonic ﬁbroblast_mm9 7/2000 3.66e-03 7.51e-02
10 H3K9me3_G1E_mm9 9/3067 2.95e-03 7.51e-02
11 H3K27me3_testis_mm9 7/2000 3.66e-03 7.51e-02
12 H3K27me3_mononuclear cell_hg19 7/2000 3.66e-03 7.51e-02
13 H3K27me3_liver_mm9 7/2000 3.66e-03 7.51e-02
14 H3K27me3_ES-Bruce4_mm9 7/2000 3.66e-03 7.51e-02
15 H3K27me3_G1E_mm9 8/2569 3.72e-03 7.51e-02
16 H3K9me3_CD14-positive
monocyte_hg19
7/2000 3.66e-03 7.51e-02
17 H3K27me3_thymus_mm9 7/2000 3.66e-03 7.51e-02
18 H4K20me1_mammary epithelial
cell_hg19
7/2000 3.66e-03 7.51e-02
19 H3K27me3_G1E-ER4_mm9 8/2653 4.53e-03 8.67e-02
(A)
(B)
Fig. 15. KEGG pathwaymapping of some of 30 genes in Table 1. (A) Calcium signaling pathway: PMCA (Atp2b1), CALM (Calm1 and Calm3), ADCY (Adcy1), CaN (Ppp3ca and Ppp3r1),
CAMK (Camk2a and Camk2b), FAK2 (Ptk2b) (B) Long term potentation: AMPAR (Gria1), AC1/8 (Adcy1), CAMKII (Camk2a and Camk2b).
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lead to changes in gene expression as a possible mechanism
mediating the effect of HDACi on fear extinction.
The relationship between Adcy1 and fear memory extinction has
been examined by others (Wieczorek et al., 2010). Wieczorek et al.(2010) reported that Adcy1/Adcy8 double KO (DKO)mouse exhibited
accelerated fear extinction. They also showed that Adcy1/Adcy8 DKO
mice exhibit reduced Ca2+ stimulated activities in the hippocampus.
Global temporal gene expression in the hippocampus was also
disturbed, which is consistent with our hypothesis that the fear
16 Y.-H. Taguchi / Neuroepigenetics 8 (2016) 1–18memory extinction in response to HDACi may be related to changes in
temporal gene expression caused by HDACi.
Although in Table 1 Adcy1 is neither an HDAC4 target nor a
component of PSD, it is an EGR1 target (see Additional ﬁle 2). In
addition to this, Adcy1 was reported to be related to many of the 30
genes (Figs. 10 and 11). As can be seen in the Additional ﬁle 1, the
expression of Adcy1 was downregulated in the sample treated by
HDACi in the report by Graff et al. which is also consistent with
ﬁndings that Adcy1/Adcy8 DKO mice exhibit accelerated fear
extinction. Thus, calcium signaling pathway dysregulation caused by
suppressed Adcy1 expression is the most plausible cause of
HDACi-induced fear extinction. Adcy1 was also reported to be
expressed in PSD (Conti et al., 2007).
There were multiple additional reports about the relationship
between a number of other genes from the set of 30 genes and fear
extinction. Atp1a3 mutation was associated with a signiﬁcantly lower
level of contextual freezing (Kirshenbaum et al., 2013, 2016). The
Camk2a, mutant mice show reduced freezing responses (Chen et al.,
1994) in fear conditioning; Camk2a is part of the calcium signaling
pathway (Fig. 15(A)), Chn1 KO mice exhibit an increase in contextual
fear learning (Iwata et al., 2014), although there were no changes in
fear extinction. ENPP2, which is a calcium binding protein (Hausmann
et al., 2011), was upregulated in Cpeb KO mice that exhibit delayed
fear extinction (Berger-Sweeney et al., 2006). Gria1, which is involved
in long term potentation (Fig. 15(B)), was enhanced in fear
conditioned training mouse (Gafford et al., 2014). Although enhanced
contextual freezing was expected for mice in an enriched environ-
ment, Kif5a KO mice failed to exhibit this enhancement (Kondo et al.,
2012). Nrgn (neurogranin) was not reported to be related to fear
extinction, but to consolidation of fear conditioning (Ressler et al.,
2002). NRGN is also known to affect synaptic transmission by
regulating the local availability of CaM, which is the protein encoded
by Calm1 and Calm3, controlling the spatiotemporal patterns of
postsynaptic Ca2+/CaM dependent signaling (Diez-Guerra, 2010).
Slc1a2, also known as Glt1, KO (heterozygous) mice exhibit less
context-based fear conditioning compared to wild type mice (Kiryk et
al., 2008). Syt1 (synaptotagmin 1), is a major Ca2+-sensor for
neurotransmitter release; knockdown of Syt1 (Syt1KD) in the
hippocampal CA1 region impaired the precision of fear memories
without impeding the acquisition of recent contextual fear memories,
while knockdown of synaptotagmin-1 in the prefrontal cortex
impaired all remote fear memories (Xu et al., 2012). Transthyretin
(TTR) was upregulated during fear conditioning training (Stork et al.,
2001). TTR was also upregulated during consolidation of long term
contextual fear memories (Levenson et al., 2004). Thus, it is plausible
that the 30 genes identiﬁed by PCA-based unsupervised FE mediate
the effects of HDACi on fear extinction by affecting various aspects of
calcium signaling.
4. Discussion
This study used the recently proposed PCA based unsupervised FE
method to reanalyze publicly available data from two distinct
experiments Gräff et al. (2014) and Hait et al. (2014) of extinction
of fear conditioning in response to two HDACi compounds (CI-994
and FTY720, respectively).
Although Gräff et al. (2014) suggested that differentially expressed
genes were accompanied by increased histone acetylation in the
respective gene promoter regions, this was only demonstrated for ﬁve
genes, for which no selection criteria were described. Thus, these
results do not exclude the possibility that HDAC4, rather than histone
acetylation, directly regulates gene expression.
In contrast to the general belief that HDACi affects gene expression
by regulating histone deacetylation mediated through HDAC, based
on the results of our re-analyses of the publicly available datasets from
the published reports by Gräff et al. (2014) and Hait et al. (2014), wepropose an alternative possibility where HDACi affects the direct
(non-canonical) regulation of HDAC target genes, especially PSD
genes. Our re-analysis of the data from these two reports suggests that
HDACi may affect the extinction of fear memory by affecting temporal
gene expression after contextual fear conditioning. Experimental
validation of these alternate mechanisms is required to validate these
predictions and the methodology used in this study.
Our work illustrates the difﬁculty and complexity of interpreting
data on altered gene expression induced by HDACi treatment and the
importance of publicly available datasets and analytical tools to gain
new insights into the mechanisms of action of these potential
therapeutic compounds.
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